EVRY, France & MUNICH, Germany--(BUSINESS WIRE)--Regulatory News:
Global Bioenergies (Paris:ALGBE) announces that the design of its second industrial pilot will be carried out by the Engineering Division of The Linde Group, a world-leading gases and engineering company.
Global Bioenergies, a NYSE Alternext Paris listed company (ALGBE), is a pioneer in the development of processes to convert renewable resources into light olefins, the key building blocks of the petrochemical industry. Its most advanced program is focused on the production of isobutene, a molecule with a multi-billion US Dollar market that cannot be accessed through the cheap C2 fraction of shale gas and natural gas. The company recently announced the choice of the Leuna refinery site for its second industrial pilot, for which the German ministry of research committed a €5.7m grant. Global Bioenergies recently strengthened its deployment in Germany by setting-up a subsidiary in Leipzig and signing a partnership on renewable gasoline with Audi.
Today, Global Bioenergies is glad to announce that Linde will carry out the design of this industrial pilot. Linde is a world leader in the field of industrial gases with more than 100 years of experience in engineering facilities using or producing industrial gases.
Markus Wolperdinger, Vice President Biotechnology Plants at Linde's Engineering Division, declares: “We regard isobutene as a very attractive gaseous molecule for a wide range of applications in chemical and industrial products. We are delighted to be chosen as Engineering Company for Global Bioenergies' second pilot plant. For the chemical site of Leuna, this project means a further strengthening of its outstanding position as a center for the commercialization of innovative biotechnological processes”
Richard Bockrath, Vice President Chemical Engineering at Global Bioenergies, adds: “Several large and recognized industrialists now constitute our sphere of collaborators: Cristal Union, Synthos, Audi, Arkema, and now Linde, a great leader in industrial gases. I expect that accessing Linde’s immense technology expertise will be a key factor of success in bringing our process to the market.”
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the yield of its process and is actively entering the industrial pilot testing phase. The company recently replicated this success to propylene and butadiene and is also looking to continue with other members of the gaseous olefins family, key molecules at the heart of petrochemical industry.
Global Bioenergies is listed on NYSE Alternext Paris (FR0011052257 – ALGBE).
About The Linde Group
The Linde Group is a world leading gases and engineering company with around 63,000 employees in more than 100 countries worldwide. In the 2012 financial year, Linde generated revenue of EUR 15.280 bn. The strategy of the Group is geared towards long-term profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment – in every one of its business areas, regions and locations across the globe. Linde is committed to technologies and products that unite the goals of customer value and sustainable development. Linde Engineering is a leading technology partner for plant engineering and construction worldwide. Linde Engineering's global success is built on extensive process engineering expertise in the planning, project development and construction of turnkey industrial plants. For more information, see The Linde Group online at www.linde.com
Should you like to be kept informed, subscribe to our news feed on